SHIGELLA INFECTION
Clinical trials for SHIGELLA INFECTION explained in plain language.
Never miss a new study
Get alerted when new SHIGELLA INFECTION trials appear
Sign up with your email to follow new studies for SHIGELLA INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a drinkable vaccine stop Shigella's grip?
⭐️ VACCINE ⭐️ CompletedThis trial tests an experimental oral vaccine, WRSs2, designed to protect against Shigella sonnei, a common cause of severe diarrhea. Healthy adults aged 18-49 receive either the vaccine or a placebo, then are later exposed to the live bacteria in a controlled setting to see if t…
Matched conditions: SHIGELLA INFECTION
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated Aug 12, 2026 00:00 UTC
-
New oral vaccine aims to tackle two Diarrhea-Causing bugs at once
⭐️ VACCINE ⭐️ CompletedThis early-stage study tested a new oral vaccine designed to protect against two bacteria that cause severe diarrhea: Shigella and ETEC. Fifty-three healthy adults received the vaccine to check for side effects and to see if it triggers an immune response. The goal is to develop …
Matched conditions: SHIGELLA INFECTION
Phase: PHASE1 • Sponsor: University of Maryland, Baltimore • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:01 UTC